7-Epi 10-desacetyl paclitaxel
CAS: 78454-17-8
Ref. 3D-IE22703
5mg | 286,00 € | ||
10mg | 420,00 € | ||
25mg | 598,00 € | ||
50mg | 854,00 € | ||
100mg | 1.339,00 € |
Produktinformation
- 10-Deacetyl-7-epi-taxol10-Deacetyl-7-epitaxol10-Desacetyl-7-epipaclitaxelPaclitaxel related compound B
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- 7-EPI-10-DEACETYL-TAXOL
- Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- 7-Epi-10-deacetyltaxol
- 7-epi-10-Deacetyltaxol
- 2'-epi-3'-epi-10-Deacetyltaxol
- 10-Deacetyl-7-epitaxol
7-Epi 10-desacetyl paclitaxel is a prodrug of paclitaxel. It has a similar mechanism of action to paclitaxel, and is used as a chemotherapeutic agent for the treatment of cancer. 7-Epi 10-desacetyl paclitaxel has shown potent apoptotic activity in cell culture, as well as in animal models. This drug is prepared by high performance liquid chromatography and is used to treat cancer. The drug may also be activated by an enzyme called adenosine diphosphate ribose (ADPR), which forms from ATP during cellular metabolism. 7-Epi 10-desacetyl paclitaxel may also have anticancer effects on cervical cancer cells due to its ability to inhibit the synthesis of DNA and RNA.
Chemische Eigenschaften
Technische Anfrage zu: 3D-IE22703 7-Epi 10-desacetyl paclitaxel
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.